节点文献

壳聚糖-磺酸甜菜碱对人肝癌HepG-2细胞的siRNA递送实验研究

Research on siRNA delivery mediated by chitosan-culfobetaine on human hepatoma HepG-2 cells

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 董伟李大玉惠景范芳李长福姜念刘云朱欣婷

【Author】 Dong Wei;Li Dayu;Hui Jing;Fan Fang;Li Changfu;Jiang Nian;Liu Yun;Zhu Xinting;Guizhou Provincial College-Based Key Lab for Tumor Prevention and Treatment with Distinctive Medicines,Zunyi Medical University;Department of Biochemistry and Molecular Biology,Zunyi Medical University;

【机构】 遵义医学院贵州省普通高等学校特色药物肿瘤防治重点实验室遵义医学院生物化学教研室

【摘要】 目的设计合成新型高分子材料壳聚糖-磺酸甜菜碱(CS-DMAAPS)化合物,并考察该材料与siRNA复凝后对人肝癌HepG-2细胞的转染能力。方法采取Michael加成法将含C=C双键的磺酸甜菜碱化合物(DMAAPS)与壳聚糖(CS)偶联接枝;利用核磁共振氢谱进行结构表征;CCK-8检测材料的细胞相容性;荧光显微镜观察siRNA的转染效率;Real-time PCR检测转染siRNA后对Bcl-2 mRNA的沉默效率。结果核磁共振氢谱数据表明:DMAAPS已成功枝接到CS上。荧光显微镜观察结果显示:质量比(m0/mt:CS-DMAAPS/siRNA)为32、16、8、4、2的复合颗粒分别转染人肝癌HepG-2细胞24 h后,转染率分别为33.78%、45.82%、50.98%、69.89%、81.22%。Real-time PCR检测结果显示:质量比为4的CS-DMAAPS/siRNA复合颗粒转染人肝癌HepG-2细胞48 h后,对人肝癌HepG-2细胞的Bcl-2基因沉默效率为26.8%。结论壳聚糖-磺酸甜菜碱(CS-DMAAPS)化合物能实现siRNA对人肝癌HepG-2细胞的转染,且细胞相容性良好,能实现目标基因的部分沉默。

【Abstract】 Objective The aim of this study is to synthesize the chitosan-sulfobetaine( CS-DMAAPS) copolymer as siRNA delivery vector,and investigate the transfection efficiency on HepG-2 cells. Methods The sulfonic acid betaine( DMAAPS) with C = C was grafted onto chitosan( CS) by Michael addition method,and the structure of the copolymer was characterized with1H-NMR. The cytocompatibility of CS-DMAAPS was examined through CCK-8 method. The transfection efficiency of CS-DMAAPS was observed with fluorescence microscopy. And the silencing efficiency of Bcl-2 gene expression was detected after siRNA gene transfection.Results NMR data showed that DMAAPS had been successfully connected to CS. The transfection efficiencies of the copolymers with different CS-DMAAPS/siRNA mass ratio( m0/mt: 32,16,8,4 and 2) were not same. They were 33. 78%,45. 82%,50. 98%,69. 89% and 81. 22%,respectively. Real-time PCR results showed that the silencing efficiency of Bcl-2 gene expression in HepG-2 cells was 26. 8% after transfection by using nanoparticles( m0/mt: 4). Conclusion CS-DMAAPS could be a feasible new gene delivery material with good biocompatibility,which could delivery siRNA into HepG-2 to inhibit the expression of Bcl-2 gene.

【基金】 贵州省科技厅社会发展攻关项目(NO:黔科合SY[2013]3008);遵义医学院招标项目(NO:F-614);贵州省教育厅特色重点实验室建设项目(NO:黔教合KY字[2014]212)
  • 【文献出处】 遵义医学院学报 ,Journal of Zunyi Medical University , 编辑部邮箱 ,2017年01期
  • 【分类号】R735.7
  • 【下载频次】105
节点文献中: 

本文链接的文献网络图示:

本文的引文网络